Which Patients Should Undergo Immediate or Deferred Cystectomy in Non-Muscle Invazive Bladder Cancer? Evaluation of Selection Criteria
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 1
Abstract
Bladder cancer is the most common malignancy of the urinary tract in Europe. 70% of all muscle invasive is bladder cancer (MIBC) at the time of diagnosis whereas remaining 30% is non-muscle invasive bladder cancer (NMIBC). NMIBC patients with low-risk can be treated with complete transurethral resection of bladder tumor (TUR-BT) and perioperative single-dose adjuvant chemotherapeutic instillation; whilst TUR-BT and bacille calmette guerin (or mitomycin) treatment are usually used in patient management with high-risk tumor. Radical cystectomy may be the choice of treatment in high-risk NMIBC. Although radical cystectomy is the definitive treatment of MIBC, its role and timing in NMIBC is still remains unclear. Early and deferred cystectomy refers two different cystectomy concepts in NMIBC without a definitive time threshold. Early cystectomy defines cystectomy in a short time span following pathologic diagnosis, whereas cystectomy performed after bladder-sparing surgery is a deferred cystectomy. Despite the difference between these studies in regard to design and outcomes, most of the conducted studies have shown immediate cystectomy to be superior to deferred cystectomy with favorable survival rates. According to previous studies and a meta-analysis, depth of invasion in lamina propria and presence of carcinoma in situ have shown to be the most significant factors supporting immediate cystectomy. Increased knowledge and surgical experience, the advantages of robotic surgery as well as orthotopic urinary diversions being used more common are some factors which may encourage clinicians and patients in decision making for an early cystectomy with functional and aesthetic advantages.
Authors and Affiliations
Şenol Tonyalı, Mustafa Sertaç Yazıcı
Keywords
Related Articles
- EP ID EP228268
- DOI 10.4274/uob.536
- Views 97
- Downloads 0
The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia
Improvements in the treatment of benign prostatic hyperplasia (BPH), which is the most common cause of lower urinary tract symptoms in aging males, are proceeding progressively. The prostatic urethral lift procedure offe...
Immunotherapy in Prostate Cancer
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (...
A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis
Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour (TUR-BT) is the standard approach to these patients. Intravesical treatments...
Targeted Agents and Resistance Mechanism in Renal Cell Cancer
Renal cell carcinoma (RCC) exhibits multidrug resistance protein P-glycoprotein expression due to the proximal tubular origin and in this regard, it is resistant to a large number of cytotoxic chemotherapy. The identific...
Importance of the Re-Transurethral Resection in Bladder Cancer Treatment
Objective: In this study, we aimed to investigate the importance of repeat-transurethral resection (re-TUR) in bladder cancer treatment. Materials and Methods: A total of 90 with the diagnosis of grade pTa and all pT1 bl...